Zimmer Biomet Holdings, Inc.
ZBH
$86.69
$1.712.01%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -7.00% | 12.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.00% | 12.11% | |||
| Cost of Revenue | -29.08% | 42.23% | |||
| Gross Profit | 5.12% | 0.43% | |||
| SG&A Expenses | 0.92% | 3.60% | |||
| Depreciation & Amortization | -8.78% | 0.68% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.18% | 16.21% | |||
| Operating Income | 31.08% | -7.90% | |||
| Income Before Tax | 207.76% | -64.94% | |||
| Income Tax Expenses | 257.89% | -183.13% | |||
| Earnings from Continuing Operations | 72.93% | -40.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -113.33% | 600.00% | |||
| Net Income | 70.93% | -39.67% | |||
| EBIT | 31.08% | -7.90% | |||
| EBITDA | 13.96% | -4.25% | |||
| EPS Basic | 72.85% | -39.40% | |||
| Normalized Basic EPS | 36.19% | -5.68% | |||
| EPS Diluted | 72.71% | -39.10% | |||
| Normalized Diluted EPS | 36.24% | -5.77% | |||
| Average Basic Shares Outstanding | -1.12% | -0.45% | |||
| Average Diluted Shares Outstanding | -1.16% | -0.35% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.42% | 0.66% | |||